Ameluz® gel is a prescription drug approved by the FDA in combination with the red light BF-RhodoLED®. It is indicated for the lesion-directed and field-directed treatment of Actinic Keratoses (“AK’s”) of mild-to-moderate severity on the face and scalp.2 Ask your doctor about Actinic Keratoses and if Ameluz® and BF-RhodoLED® may be right for you.

During the light treatment, you may experience sensations of burning, tingling, stinging, or prickling of the treated AKs. Following treatment, the AKs and to some degree the surrounding skin may redden, and swelling and scaling may also occur. These effects are temporary and should completely resolve by 2 weeks after treatment. Avoid exposure of your treated skin to sunlight for at least 48 hours.

Insurance Coverage

This treatment is generally covered by insurance. Patients should check with their individual insurance carriers regarding coverage.